A-803467
(Synonyms: 5-(4-氯苯基)-N-(3,5-二甲氧基苯基)-2-呋喃甲酰胺) 目录号 : GC15701
A-803467是一种河豚毒素耐受型Nav1.8钠通道的阻断剂,其阻断人Nav1.8钠通道的IC50为8nM。
Cas No.:944261-79-4
Sample solution is provided at 25 µL, 10mM.
A-803467 is a tetrodotoxin-resistant Nav1.8 sodium channel blocker which can block human Nav1.8 with an IC50 of 8nM [1, 2]. A-803467 can effectively block experimental inflammatory and neuropathic pain caused by the Nav1.8 channel [1].
A-803467 (7.5μM; 2h) enhanced the intracellular [3H]-MX accumulation in ABCG2-transfected HEK293 cells [2]; A-803467 (7.5μM; 0, 30, 60, 120min) significantly blocked the intracellular [3H]-MX efflux from ABCG2-transfected cells [2]; A-803467 (100nM) caused significant current blocking in HEK-293 cells expressing the human Nav1.8 sodium channel [1]; A-803467 (30nM) shortened action potential in mouse ventricular myocytes at slow frequency (0.1Hz) stimulus current [3]; A-803467 (30nM; 15min) reduced frequency of diastolic Ca2+ waves in human atrial cardiomyocytes from patients with sinus rhythm [4].
A-803467 (10, 30, 100mg/kg; i.p.) potently reduced thermal hyperalgesia in the complete Freund’s adjuvant (CFA) Sprague-Dawley (SD) rat model of inflammatory pain [1]; A-803467 (10, 30, 100mg/kg; i.p.) reduced mechanical allodynia in the L5/L6 spinal nerve injury model of SD rats [1]; A-803467 (10, 30, 100mg/kg; i.p.) reduced mechanical allodynia in the chronic constriction injury of the sciatic nerve model of SD rats [1]; A-803467 (10mg/rat; i.a.) reduced joint pain of male Wistar rats which induced by monoiodoacetate (MIA) [5].
References:
[1] Jarvis M F, Honore P, Shieh C C, et al. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat [J]. Proceedings of the National Academy of Sciences of the United States of America, 2007, 104(20): 8520-8525.
[2] Anreddy N, Patel A, Zhang Y K, et al. A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo [J]. Oncotarget, 2015, 6(36): 39276-39291.
[3] Yang T, Atack T C, Stroud D M, et al. Blocking Scn10a channels in heart reduces late sodium current and is antiarrhythmic [J]. Circulation research, 2012, 111(3): 322-332.
[4] Pabel S, Ahmad S, Tirilomis P, et al. Inhibition of Nav1.8 prevents atrial arrhythmogenesis in human and mice [J]. Basic research in cardiology, 2020, 115(2): 20.
[5] Schuelert N, McDougall J J. Involvement of Nav1.8 sodium ion channels in the transduction of mechanical pain in a rodent model of osteoarthritis [J]. Arthritis research & therapy, 2012, 14(1): R5.
A-803467是一种河豚毒素耐受型Nav1.8钠通道的阻断剂,其阻断人Nav1.8钠通道的IC50为8nM[1, 2]。A-803467可以有效阻断Nav1.8 通道导致的实验性炎症和神经性疼痛[1]。
A-803467(7.5μM;2h)增加了ABCG2转染的HEK293细胞内[3H]-MX的积累[2];A-803467(7.5μM;0、30、60、120min)显著阻断ABCG2转染的HEK293细胞内的[3H]-MX外流[2];A-803467(100nM)使表达人Nav1.8钠通道的HEK-293细胞产生了明显的电流阻滞[1];A-803467 (30nM)在慢频率(0.1Hz)的刺激电流下可以缩短小鼠心室肌细胞的动作电位[3];A-803467 (30nM;15min)降低了窦性心律患者的人心房心肌细胞的舒张压 Ca2+波频率[4]。
A-803467(10、30、100mg/kg;i.p.)可以有效减轻CFA(complete Freund’s adjuvant)诱导的SD大鼠(Sprague-Dawley)炎症性疼痛模型的热痛觉过敏[1];A-803467(10、30、100mg/kg;i.p,)可减轻L5/L6脊髓神经损伤SD大鼠模型的触诱发痛[1];A-803467(10、30、100mg/kg;i.p,)可减轻坐骨神经慢性收缩损伤SD大鼠模型的触诱发痛[1];A-803467(10mg/只;i.a.)可以减轻MIA(monoiodoacetate)诱导的雄性Wistar大鼠的关节疼痛[5]。
| Cell experiment [1]: | |
Cell lines | HEK293 |
Preparation Method | ABCG2-transfected cells were established by transfecting HEK293 cell with pcDNA3.1 vector containing a full-length ABCG2, and then ABCG2-transfected cells were incubated with [3H]-MX (a kind of substrate of ABCG2), with or without 7.5μM A-803467 for 2h. |
Reaction Conditions | 7.5μM; 2h |
Applications | A-803467 significantly enhanced the intracellular [3H]-MX accumulation in ABCG2-transfected cells. |
| Animal experiment [2]: | |
Animal models | Male Sprague-Dawley rats |
Preparation Method | Unilateral inflammation of rats was induced by injecting CFA (complete Freund’s adjuvant), A-803467 was injected 90min after CFA injection, the behavioral testing for thermal hyperalgesia was conducted 2d later. |
Dosage form | 10, 30, 100mg/kg; i.p. |
Applications | A-803467 potently reduced thermal hyperalgesia in the CFA model of inflammatory pain. |
[1] Anreddy N, Patel A, Zhang Y K, et al. A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo [J]. Oncotarget, 2015, 6(36): 39276-39291. | |
| Cas No. | 944261-79-4 | SDF | |
| 别名 | 5-(4-氯苯基)-N-(3,5-二甲氧基苯基)-2-呋喃甲酰胺 | ||
| 化学名 | 5-(4-chlorophenyl)-N-(3,5-dimethoxyphenyl)furan-2-carboxamide | ||
| Canonical SMILES | COC1=CC(=CC(=C1)NC(=O)C2=CC=C(O2)C3=CC=C(C=C3)Cl)OC | ||
| 分子式 | C19H16ClNO4 | 分子量 | 357.79 |
| 溶解度 | ≥ 13.95mg/mL in DMSO | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.7949 mL | 13.9747 mL | 27.9494 mL |
| 5 mM | 559 μL | 2.7949 mL | 5.5899 mL |
| 10 mM | 279.5 μL | 1.3975 mL | 2.7949 mL |
| 第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
| 给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
| 第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
















